REG - Cerillion PLC - Change of Adviser

CerillionAnnouncement

16/03/2020 07:00

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200316:nRSP1318Ga

RNS Number : 1318G  Cerillion PLC  16 March 2020

16 March 2020

 

Cerillion plc

("Cerillion" or "the Company")

 

Appointment of Liberum as NOMAD and Corporate Broker

 

Cerillion, the billing, charging and customer relationship management ("CRM")
software solutions provider, is pleased to announce the appointment of Liberum
Capital Limited ("Liberum") as its Nominated Adviser and sole corporate broker
with immediate effect.

 

 

 Cerillion plc                          c/o KTZ Communications
 Louis Hall, CEO                        T: 020 3178 6378
 Oliver Gilchrist, CFO

 Liberum (Nomad and Broker)             T: 020 3100 2000
 Bidhi Bhoma, Euan Brown, William Hall

 KTZ Communications                     T: 020 3178 6378
 Katie Tzouliadis, Dan Mahoney

 

 

Update to disclosures required by Schedule 2(g) of the AIM Rules for Companies

In addition to the directorships disclosed in the Company's admission document
dated 14 March 2016, Alan Howarth, Louis Hall, Oliver Gilchrist and Guy
O'Connor were, at that time, also directors of Cerillion Technologies Limited
(Malta).

 

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing,
charging and customer relationship management ("CRM"), mainly serving the
telecommunications market but also other sectors such as utilities and
financial services. The Company currently has over 90 customer installations
across over 40 countries.

 

Headquartered in London, Cerillion also has operations in Pune, India, where
its Global Solutions Centre is located, Miami and Sydney.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.   END  APPJJMJTMTBBBAM